pDC secretion of type I IFNs can enhance anti-tumor immune responses through macrophage activation, the stimulation of natural killer (NK) and CD8+ T cell cytotoxicity, and the promotion of DC maturation [22]. This evidence concerns the gene CD8A and neoplasm.